Recent News

Last Updated:

February 10, 2012

Apoptrol, LLC, is pleased to announce our recent licensing agreement with The University of Toledo in adding anti-alpha catenin and anti-desmoglein2 antibodies to Apoptrol’s expanding cell death reagent product line. The addition of these antibodies represents an exciting new line of reagents that we are now able to offer researchers working in the fields of cell death, differentiation, and development.

December 27, 2011

Apoptrol, LLC, is pleased to introduce our newest products In Vivo Go! QVD and QVE. In Vivo Go! QVD is a ready to use pan-caspase inhibitor specifically formulated for in vivo studies. In Vivo Go! QVE is a ready to use, negative control that is specifically formulated for in vivo studies for parallel studies with QVD. In addition to superior quality and reproducibility, In Vivo Go! reagents save you time and precious research dollars to facilitate your research.

August 10, 2011

Apoptrol, LLC, is pleased to announce our recent agreement with Maxim Pipetting Services, Inc. to add Maxim Pipettors to Apoptrol’s expanding product line. The addition of Maxim pipettors at a significantly lower price, demonstrates our commitment to facilitate your science without sacrificing the highest standards of quality. The new agreement between Apoptrol, LLC and Maxim is a prime example of how biotechnology companies can work together to break down old walls and build new bridges to the future. We look forward to our new working arrangements and future interactions.

July 25, 2011

Apoptrol, LLC, is pleased to announce our recent licensing agreement with Boise State University and Bioscience Bridge, LLC in adding caspase-cleaved Beclin-1 antibody to Apoptrol’s expanding cell death reagent product line. The addition of this antibody represents an exciting new line of reagents that we are now able to offer researchers working in the fields of cell death, differentiation, and development. The new agreement, brokered between Apoptrol, LLC and Boise State’s Technology Transfer department is a prime example of academia and the biotechnology industry working together to achieve common goals in a collegial, streamlined and efficient manner to allow us to come to a mutually acceptable agreement. We look forward to our new working arrangements and future possibilities.

Apoptrol, LLC
PO Box 32, Enon, OH 45323-0032
Phone: 937-623-8729